PB
Pedro Beltran
DELAYED 1 MONTH
Chief Scientific Officer; Director, President and CEO
BridgeBio Oncology Therapeutics, Inc.
Filings
3
Companies
1
Latest
May 10, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.